106 related articles for article (PubMed ID: 9772292)
1. Polyamine metabolism as target for cancer chemoprevention (review).
Seiler N; Atanassov CL; Raul F
Int J Oncol; 1998 Nov; 13(5):993-1006. PubMed ID: 9772292
[TBL] [Abstract][Full Text] [Related]
2. Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.
Battaglia V; DeStefano Shields C; Murray-Stewart T; Casero RA
Amino Acids; 2014 Mar; 46(3):511-9. PubMed ID: 23771789
[TBL] [Abstract][Full Text] [Related]
3. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications.
Thomas T; Thomas TJ
Cell Mol Life Sci; 2001 Feb; 58(2):244-58. PubMed ID: 11289306
[TBL] [Abstract][Full Text] [Related]
4. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.
Lian J; Liang Y; Zhang H; Lan M; Ye Z; Lin B; Qiu X; Zeng J
Front Immunol; 2022; 13():912279. PubMed ID: 36119047
[TBL] [Abstract][Full Text] [Related]
5. Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism.
Arruabarrena-Aristorena A; Zabala-Letona A; Carracedo A
Sci Adv; 2018 Jan; 4(1):eaar2606. PubMed ID: 29376126
[TBL] [Abstract][Full Text] [Related]
6. Maybe the various forms of kidney disease are not so mechanistically different?
Evans RG
Kidney Int; 2023 Jul; 104(1):31-33. PubMed ID: 37349058
[TBL] [Abstract][Full Text] [Related]
7. Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target.
Wolters-Eisfeld G; Hackert T; Güngör C
Signal Transduct Target Ther; 2023 Oct; 8(1):410. PubMed ID: 37884518
[No Abstract] [Full Text] [Related]
8. Editorial to the Special Issue on "Polyamine Metabolism in Health and Disease: Potential for Polyamine-Targeted Therapies and Prevention".
Stewart TM
Med Sci (Basel); 2023 Aug; 11(3):. PubMed ID: 37606432
[TBL] [Abstract][Full Text] [Related]
9. Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
Zhang T; Hu L; Tang JF; Xu H; Tian K; Wu MN; Huang SY; Du YM; Zhou P; Lu RJ; He S; Xu JM; Si JJ; Li J; Chen DL; Ran JH
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915902
[TBL] [Abstract][Full Text] [Related]
10. Baicalein, 7,8-Dihydroxyflavone and Myricetin as Potent Inhibitors of Human Ornithine Decarboxylase.
Liu YC; Liu YL; Hsieh JY; Wang CH; Lin CL; Liu GY; Hung HC
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33348871
[TBL] [Abstract][Full Text] [Related]
11. Polyamine Metabolism as a Therapeutic Target inHedgehog-Driven Basal Cell Carcinomaand Medulloblastoma.
Coni S; Di Magno L; Serrao SM; Kanamori Y; Agostinelli E; Canettieri G
Cells; 2019 Feb; 8(2):. PubMed ID: 30754726
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase as a therapeutic target for endometrial cancer.
Kim HI; Schultz CR; Buras AL; Friedman E; Fedorko A; Seamon L; Chandramouli GVR; Maxwell GL; Bachmann AS; Risinger JI
PLoS One; 2017; 12(12):e0189044. PubMed ID: 29240775
[TBL] [Abstract][Full Text] [Related]
13. A Cross-Sectional Study: Nutritional Polyamines in Frequently Consumed Foods of the Turkish Population.
Buyukuslu N; Hizli H; Esin K; Garipagaoglu M
Foods; 2014 Oct; 3(4):541-557. PubMed ID: 28234336
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of ornithine decarboxylase, diamine oxidase, putrescine, and spermine in normal canine enterocolic mucosa, in chronic colitis, and in colorectal cancer.
Rossi G; Cerquetella M; Pengo G; Mari S; Balint E; Bassotti G; Manolescu N
Biomed Res Int; 2015; 2015():172756. PubMed ID: 26550563
[TBL] [Abstract][Full Text] [Related]
15. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.
Verlinden BK; de Beer M; Pachaiyappan B; Besaans E; Andayi WA; Reader J; Niemand J; van Biljon R; Guy K; Egan T; Woster PM; Birkholtz LM
Bioorg Med Chem; 2015 Aug; 23(16):5131-43. PubMed ID: 25684422
[TBL] [Abstract][Full Text] [Related]
16. Functional roles of the dimer-interface residues in human ornithine decarboxylase.
Lee CY; Liu YL; Lin CL; Liu GY; Hung HC
PLoS One; 2014; 9(8):e104865. PubMed ID: 25140796
[TBL] [Abstract][Full Text] [Related]
17. Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.
Coker-Gürkan A; Arisan S; Arisan ED; Unsal NP
Biomed Rep; 2014 Jan; 2(1):69-74. PubMed ID: 24649071
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition overcomes drug resistance through a miRNA-dependent mechanism.
Murray-Stewart T; Hanigan CL; Woster PM; Marton LJ; Casero RA
Mol Cancer Ther; 2013 Oct; 12(10):2088-99. PubMed ID: 23943804
[TBL] [Abstract][Full Text] [Related]
19. Unbiased metabolite profiling indicates that a diminished thymidine pool is the underlying mechanism of colon cancer chemoprevention by alpha-difluoromethylornithine.
Witherspoon M; Chen Q; Kopelovich L; Gross SS; Lipkin SM
Cancer Discov; 2013 Sep; 3(9):1072-81. PubMed ID: 23771434
[TBL] [Abstract][Full Text] [Related]
20. Involvement of polyamines in iron(III) transport in human intestinal Caco-2 cell lines.
Lescoat G; Gouffier L; Cannie I; Lowe O; Morel I; Lepage S; Ropert M; Loréal O; Brissot P; Gaboriau F
Mol Cell Biochem; 2013 Jun; 378(1-2):205-15. PubMed ID: 23494528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
